Get the Stockscreener App
0.635
11.09%
0.0634
After Hours:
.64
0.005
+0.79%
Helius Medical Technologies Inc stock is traded at $0.635, with a volume of 253.74K.
It is up +11.09% in the last 24 hours and down -11.34% over the past month.
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.
See More
Previous Close:
$0.5716
Open:
$0.599
24h Volume:
253.74K
Relative Volume:
0.06
Market Cap:
$2.37M
Revenue:
$502.00K
Net Income/Loss:
$-8.86M
P/E Ratio:
-0.112
EPS:
-5.67
Net Cash Flow:
$-10.71M
1W Performance:
-18.59%
1M Performance:
-11.34%
6M Performance:
-12.41%
1Y Performance:
-90.84%
1-Day Range:
$0.5701
$0.668
1-Week Range:
$0.5436
$0.7799
52-Week Range:
$0.373
$9.50
Helius Medical Technologies Inc Stock (HSDT) Company Profile
Name
Helius Medical Technologies Inc
Sector
Industry
Phone
215-944-6100
Address
642 NEWTOWN YARDLEY ROAD, NEWTOWN, PA
Compare HSDT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HSDT
Helius Medical Technologies Inc
|
0.635 | 2.37M | 502.00K | -8.86M | -10.71M | -5.67 |
|
ABT
Abbott Laboratories
|
128.81 | 223.42B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
103.04 | 151.86B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
390.43 | 148.84B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
91.99 | 117.96B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
73.22 | 43.19B | 6.60B | 4.16B | 490.10M | 6.93 |
Helius Medical Technologies Inc Stock (HSDT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-24-21 | Initiated | Noble Capital Markets | Outperform |
Helius Medical Technologies Inc Stock (HSDT) Latest News
Enrollment for Helius Stroke Pivotal Study Exceeds Initial Target - Physical Therapy Products
PoNS therapy shows promise for MS gait deficits - MSN
PoNSTEP Study Confirms Long-Term Benefits of PoNS Therapy for MS Patients - MSN
Helius Medical Tech (NASDAQ:HSDT) Stock Quotes, Forecast and News Summary - Benzinga
Helius Medical Secures Funds Through Warrant Agreements - TipRanks
HSDTHelius Medical Technologies, Inc. Latest Stock News & Market Updates - StockTitan
Helius Medical Surpasses Enrollment Target for Stroke Program - MSN
Helius Medical Technologies, Inc. Announces Exercise of - GlobeNewswire
Helius Medical Technologies, Inc. Announces First Clinical Evidence of Positive Long-term Therapeutic Effects of PoNS Therapy® on Gait Deficit Improvement in Multiple Sclerosis from the PoNS® Therapeutic Experience Program Study - The Manila Times
Helius Medical Technologies, Inc. Announces First Clinical - GlobeNewswire
Helius Medical Technologies, Inc. Announces First Clinical Evidence of Positive Long-term ... - The Bakersfield Californian
Helius exceeds stroke study enrollment goals By Investing.com - Investing.com Australia
Helius Medical's MS Therapy Shows Breakthrough Results in Long-Term Gait Study - StockTitan
Helius Medical Raises $3.7M Through Warrant Exercise at $0.751, Issues New Warrants - StockTitan
Helius Medical Technologies, Inc. Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $3.7 Million Gross Proceeds Priced At-the-Market - The Manila Times
KBW Regional Banking Index (KRX) QuotePress Release - The Globe and Mail
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
TSX Venture Composite Index (JX) QuotePress Release - The Globe and Mail
KBW Finsec Dividend Yield Index (KDX) QuotePress Release - The Globe and Mail
TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail
TSX Global Base Metals Index (TXBM) QuotePress Release - The Globe and Mail
Stock market news: Canoo saw fall of 72.18% while U.S. Energy witnessed surge of 122.45% during mid day trading - Business Upturn
Stock market today: Canoo declined by 63.15% while Asset Entities posted gains of 166.95% in early trading - Business Upturn
Dow Jumps 200 Points; 3M Posts Upbeat Q4 Results - Benzinga
Helius exceeds stroke study enrollment goals - MSN
Helius Medical Technologies, Inc. Announces Strong Enrollment of Its Stroke Pivotal Study Exceeding Initial Target - Marketscreener.com
Helius Medical Technologies, Inc. Announces Strong Enrollment of its Stroke Pivotal Study Exceeding Initial Target - GlobeNewswire
Helius Medical Surpasses Stroke Trial Enrollment Goals for Revolutionary PoNS Device - StockTitan
There Is A Lot Of Upside Potential For Helius Medical Technologies Inc(NASDAQ: HSDT) - Stocks Register
Helius Medical Technologies Reports Medicare Reimbursement UpdateNEWDOWNTOPTITLEHelius Medical Technologies, Inc., a Delaware-based company listed on the Nasdaq Stock Market under the symbol HSDT, recently disclosed an important event th - Defense World
Global X Fertilizers/Potash ETF (NYSEARCA:SOIL) Shares Up 0.6% – Should You Buy? - Defense World
Morgan Stanley Cushing MLP High Income Index ETN (NYSEARCA:MLPY) Trading Down 0.4% – Should You Sell? - Defense World
ETF Industry Exposure & Financial Services ETF (NYSEARCA:TETF) Stock Price Up 0.2% – Here’s What Happened - Defense World
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Helius Medical secures Medicare payment rates for PoNS device - Investing.com
Helius Medical secures Medicare payment rates for PoNS device By Investing.com - Investing.com South Africa
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Why Vision Marine Technologies Shares Are Trading Higher By 68%; Here Are 20 Stocks Moving Premarket - Benzinga
Helius Medical Technologies (NASDAQ:HSDT) Trading Up 4.8% – Still a Buy? - Defense World
Helius Medical Achieves Key Milestone with First PoNS System Sale to VA - MSN
Lockheed Martin Corp (LMT-N) QuotePress Release - The Globe and Mail
Thinking about buying stock in Scilex Holding, iCoreConnect, Genius Group, Helius Medical Technologies, or TradeUP Acquisition? - Marketscreener.com
Helius Medical Technologies, Inc. Announces First PoNS System Sale to VA Healthcare SystemOn December 23, 2024, Helius Medical Technologies, Inc. (NASDAQ:HSDT) disclosed its successful sale of the first Portable Neuromodulation Stimulator (PoNS) - Defense World
Why Carbon Revolution Shares Are Trading Higher By Around 62%; Here Are 20 Stocks Moving Premarket - Benzinga
Helius Announces First Portable Neuromodulation Stimulator (PoNS®) System Sale to the Veterans Affairs (VA) Healthcare System - The Manila Times
Helius Announces First Portable Neuromodulation Stimulator - GlobeNewswire
Neurorehabilitation Market Expected to Reach USD 6.18 - GlobeNewswire
Micron Technology (MU-Q) QuotePress Release - The Globe and Mail
Helius Medical Technologies, Inc. (NASDAQ:HSDT) Sees Large Drop in Short Interest - Defense World
Helius Medical Technologies Lists on the Canadian Securities ExchangeVideo News Alert on Investmentpitch.com - Marketscreener.com
Nvidia Corp (NVDA-Q) QuotePress Release - The Globe and Mail
Helius Medical Technologies Inc Stock (HSDT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):